{"id":2055,"date":"2021-08-13T20:43:15","date_gmt":"2021-08-13T20:43:15","guid":{"rendered":"http:\/\/wp.cov19longhaulfoundation.org\/?p=2055"},"modified":"2021-08-13T20:43:15","modified_gmt":"2021-08-13T20:43:15","slug":"good-news-mild-covid-19-induces-lasting-antibody-protection","status":"publish","type":"post","link":"https:\/\/cov19longhaulfoundation.org\/?p=2055","title":{"rendered":"Good news: Mild COVID-19 induces lasting antibody protection"},"content":{"rendered":"\n<p class=\"has-medium-font-size\"><strong>People who have had mild illness develop antibody<\/strong>&#8211;<strong>producing cells that can<\/strong> <strong>last lifetime<\/strong><\/p>\n\n\n\n<p>Authors: by\u00a0<a href=\"https:\/\/medicine.wustl.edu\/news\/author\/tbhandari\/\">Tamara Bhandari<\/a>\u2022May 24, 2021<\/p>\n\n\n\n<p style=\"font-size:24px\">Months after recovering from mild cases of COVID-19, people still have immune cells in their body pumping out antibodies against the virus that causes COVID-19, according to a study from researchers at Washington University School of Medicine in St. Louis. Such cells could persist for a lifetime, churning out antibodies all the while.<\/p>\n\n\n\n<p style=\"font-size:24px\">The findings, published May 24 in the journal Nature, suggest that mild cases of COVID-19 leave those infected with lasting antibody protection and that repeated bouts of illness are likely to be uncommon.<\/p>\n\n\n\n<p style=\"font-size:24px\">\u201cLast fall, there were reports that antibodies wane quickly after infection with the virus that causes COVID-19, and mainstream media interpreted that to mean that immunity was not long-lived,\u201d said senior author\u00a0<a href=\"https:\/\/pathology.wustl.edu\/people\/ali-ellebedy-phd\/\">Ali Ellebedy, PhD<\/a>, an associate professor of pathology &amp; immunology, of medicine and of molecular microbiology. \u201cBut that\u2019s a misinterpretation of the data. It\u2019s normal for antibody levels to go down after acute infection, but they don\u2019t go down to zero; they plateau. Here, we found antibody-producing cells in people 11 months after first symptoms. These cells will live and produce antibodies for the rest of people\u2019s lives. That\u2019s strong evidence for long-lasting immunity.\u201d<\/p>\n\n\n\n<p class=\"has-large-font-size\">For More Information: <a href=\"https:\/\/medicine.wustl.edu\/news\/good-news-mild-covid-19-induces-lasting-antibody-protect\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/medicine.wustl.edu\/news\/good-news-mild-covid-19-induces-lasting-antibody-protect<\/a>ion\/<\/p>\n","protected":false},"excerpt":{"rendered":"<p>People who have had mild illness develop antibody&#8211;producing cells that can last lifetime Authors: by\u00a0Tamara Bhandari\u2022May 24, 2021 Months after recovering from mild cases of COVID-19, people still have immune [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":2056,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[979,22,981,1005,101,836,1000,890],"tags":[],"class_list":["post-2055","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-antibody-immune-system","category-antibody","category-anigen","category-bone-marrow","category-covid-19","category-immune-system","category-natural-immunity","category-natural-immunity-immune-system"],"_links":{"self":[{"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/posts\/2055","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2055"}],"version-history":[{"count":0,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/posts\/2055\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/media\/2056"}],"wp:attachment":[{"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2055"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2055"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2055"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}